These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2758872)

  • 21. Stenotrophomonas (Xanthomonas) maltophilia: in vitro susceptibility to selected antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1998; 44(5):293-304. PubMed ID: 9732143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods.
    Swenson JM; Killgore GE; Tenover FC
    J Clin Microbiol; 2004 Nov; 42(11):5102-8. PubMed ID: 15528702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evolution of antimicrobial susceptibility of Acinetobacter baumannii clinical isolates].
    López-Hernández S; Alarcón T; López-Brea M
    Rev Esp Quimioter; 2000 Dec; 13(4):394-400. PubMed ID: 11498706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility of Acinetobacter species.
    Seifert H; Baginski R; Schulze A; Pulverer G
    Antimicrob Agents Chemother; 1993 Apr; 37(4):750-3. PubMed ID: 8494371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility of Acinetobacter clinical isolates and emerging antibiogram trends for nosocomial infection management.
    Sohail M; Rashid A; Aslam B; Waseem M; Shahid M; Akram M; Khurshid M; Rasool MH
    Rev Soc Bras Med Trop; 2016; 49(3):300-4. PubMed ID: 27384826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross resistance to ciprofloxacin and other antimicrobial agents among clinical isolates of Acinetobacter calcoaceticus biovar anitratus.
    Shalit I; Dan M; Gutman R; Gorea A; Berger SA
    Antimicrob Agents Chemother; 1990 Mar; 34(3):494-5. PubMed ID: 2185692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined defibrinated human blood and antimicrobial drug activities against Enterobacter cloacae.
    Traub WH; Spohr M
    Chemotherapy; 1983; 29(6):395-400. PubMed ID: 6653172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
    Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
    J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Streptococcus faecalis: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1986; 32(3):270-85. PubMed ID: 3086051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
    Joly-Guillou ML; Bergogne-Berezin E
    Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ro 17-2301: in vitro comparison with aztreonam, imipenem, ceftazidime, cefotaxime and netilmicin.
    Digranes A; Dibb WL; Benonisen E; Salveson A
    Chemotherapy; 1985; 31(4):279-85. PubMed ID: 3928281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between existence of integrons and multi-drug resistance in Acinetobacter isolated from patients in southern Iran.
    Japoni S; Japoni A; Farshad S; Ali AA; Jamalidoust M
    Pol J Microbiol; 2011; 60(2):163-8. PubMed ID: 21905635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibiotic sensitivity of Acinetobacter calcoaceticus in patients with infected burns].
    Borisova OK; Makarenkova RV; Bogatova IS; Kutsidi EV
    Antibiotiki; 1982 Jun; 27(6):447-50. PubMed ID: 7114831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004.
    Unal S; Garcia-Rodriguez JA
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):265-71. PubMed ID: 16360550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus.
    Bergogne-Berezin E; Joly-Guillou ML
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():35-9. PubMed ID: 3546246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial susceptibilities of clinical isolates of Acinetobacter baumannii from Singapore.
    Kuah BG; Kumarasinghe G; Doran J; Chang HR
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2502-3. PubMed ID: 7840598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and in-vitro antimicrobial susceptibility patterns of Acinetobacter strains isolated from patients in intensive care units.
    Aktas O; Ozbek A
    J Int Med Res; 2003; 31(4):272-80. PubMed ID: 12964502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro susceptibility of clinical isolates of Serratia species to antimicrobial agents.
    Sofianou D; Proya E; Kondodimou A
    J Chemother; 1990 Apr; 2(2):79-81. PubMed ID: 2362189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acinetobacter calcoaceticus bacteremia: analysis of 48 cases.
    Chen YC; Chang SC; Hsieh WC; Luh KT
    J Formos Med Assoc; 1991 Oct; 90(10):958-63. PubMed ID: 1685177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.